Biocon Biologics Secures Canadian Aflibercept Launch

Yesafili Biosimilar Rival To Eylea Can Launch In Canada By Mid-2025 Under Settlement

 
• By David Wallace
  
Canada
Biocon has struck a deal to allow a Canadian aflibercept launch
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business